J3357 HCPCS Level II code: Ustekinumab, for subcutaneous injection, 1 mg
J3357 is the HCPCS code for “Ustekinumab, for subcutaneous injection, 1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J3357Ustekinumab, for subcutaneous injection, 1 mg
Short description: Ustekinumab sub cu inj, 1 mg
HCPCS · United States
Medicare details
The indicators CMS publishes with J3357 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 2011
Where J3357 sits
- 1J codesDrugs administered other than orally
- 2Active code J3357Ustekinumab, for subcutaneous injection, 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J3357 mean?
J3357 is the HCPCS code for “Ustekinumab, for subcutaneous injection, 1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J3357?
CMS lists J3357’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J3357
All J codesJ3310Injection, perphenazine, up to 5 mgJ3315Injection, triptorelin pamoate, 3.75 mgJ3316Injection, triptorelin, extended-release, 3.75 mgJ3320Injection, spectinomycin dihydrochloride, up to 2 gmJ3350Injection, urea, up to 40 gmJ3355Injection, urofollitropin, 75 iuJ3358Ustekinumab, for intravenous injection, 1 mgJ3360Injection, diazepam, up to 5 mgJ3364Injection, urokinase, 5000 iu vialJ3365Injection, iv, urokinase, 250,000 i.u. vialJ3370Injection, vancomycin hcl, 500 mgJ3371Injection, vancomycin hcl (mylan), not therapeutically equivalent to j3370, 500 mg